Trace Neuroscience
United States · Founded 2024 · $101.0M raised
- Founded
- 2024
- Business Model
- B2B
- Website
- traceneuro.com
- Total Funding
- $101.0M
- Last Round
- $101.0M Series ANov 2024
- Rounds
- 1
About
Biopharmaceutical company developing genomic medicine for ALS, focused on UNC13A restoration as a treatment target.
Summary
Trace Neuroscience is a Biotech company based in United States, founded in 2024. It has raised $101.0M in total across 1 round, most recently a $101.0M Series A round in Nov 2024. Investors include Third Rock Ventures, Atlas Venture and GV.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2024
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.